Published in Proc Natl Acad Sci U S A on June 01, 1974
Purification from rat sarcolemma of the saxitoxin-binding component of the excitable membrane sodium channel. Proc Natl Acad Sci U S A (1980) 1.80
Characteristics of saxitoxin binding to the sodium channel of sarcolemma isolated from rat skeletal muscle. J Physiol (1979) 1.24
Isolation and characterization of muscle membranes using surface-specific labels. Proc Natl Acad Sci U S A (1977) 0.86
Acetylcholine receptors in the ciliary ganglion and in the iris muscle of the chick: specific binding and effect on the synaptic transmission of the neurotoxin from Naja naja siamensis. Br J Pharmacol (1979) 0.78
Neural regulation of acetylcholine receptors in rat neonatal muscle. J Physiol (1992) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry (1971) 66.90
Acetylcholine receptors in muscle fibres. Nature (1971) 5.14
Isolation of the cholinergic receptor protein of Torpedo electric tissue. Nature (1971) 3.36
Binding of -bungarotoxin to acetylcholine receptors in mammalian muscle (snake venom-denervated muscle-neonatal muscle-rat diaphragm-SDS-polyacrylamide gel electrophoresis). Proc Natl Acad Sci U S A (1972) 3.34
Chemical characterization and surface orientation of the major glycoprotein of the human erythrocyte membrane. Proc Natl Acad Sci U S A (1972) 3.27
Acetylcholine receptors: number and distribution at neuromuscular junctions in rat diaphragm. Science (1972) 3.03
Solid state lactoperoxidase: a highly stable enzyme for simple, gentle iodination of proteins. Biochem Biophys Res Commun (1972) 3.01
Insulin interactions with liver plasma membranes. Independence of binding of the hormone and its degradation. J Biol Chem (1972) 2.78
Isolation of synaptic vesicles and structural organization of the acetycholine system within brain nerve endings. J Neurochem (1963) 2.13
Purification from Torpedo marmorata electric tissue of membrane fragments particularly rich in cholinergic receptor protein. FEBS Lett (1972) 2.09
Chromatographic separation of the venom of Bungarus multicinctus and characterization of its components. J Chromatogr (1972) 2.00
A radiometric microassay of acetylcholinesterase. J Pharmacol Exp Ther (1967) 1.73
[Determination of orthophosphate in the presence of phosphate compounds with an affinity for acids and molybdate]. Biochem Z (1958) 1.49
BINDING OF CALCIUM IONS TO CELL MEMBRANE ISOLATED FROM BULLFROG SKELETAL MUSCLE. Am J Physiol (1964) 1.46
"Disjunction" of frog neuromuscular synapses by treatment with proteolytic enzymes. Nat New Biol (1971) 1.26
Elapid neurotoxins. Purification, characterization, and immunochemical studies of -bungarotoxin. Biochemistry (1972) 1.26
Isolation of skeletal muscle cell membrane and some of its properties. Arch Biochem Biophys (1961) 1.24
Demonstration of a specific -bungarotoxin binding component in electrophorus electricus electroplax membranes. Biochem Biophys Res Commun (1971) 1.22
Specificity of -bungarotoxin binding to Torpedo californica electroplax. Arch Biochem Biophys (1972) 1.20
Enzyme markers in characterization of isolated plasma membranes. Enzyme (1972) 1.19
[Separation of excitable membranes from the electric organ of Electrophorus electricus]. C R Acad Sci Hebd Seances Acad Sci D (1969) 1.15
The separation and partial purification of membrane-bound (Na + + K + )-dependent Mg 2+ -ATPase and (Na + +K + (Na + +K + )-independent Mg 2+ -ATPase from frog skeletal muscle. Biochim Biophys Acta (1970) 0.95
Characterization of (Na + ,K + )-ATPase isolated from embryonic chick hearts and cultured chick heart cells. Biochim Biophys Acta (1971) 0.93
A (Na+ K+) ATPase of sarcolemma from skeletal muscle. Biochem Biophys Res Commun (1970) 0.90
Isolation of skeletal muscle membrane fragments containing active Na+-K+ stimulated ATPase: comparison of normal and dystrophic muscle sarcolemma. Biochem Biophys Res Commun (1971) 0.86
SOME PROPERTIES OF THE MONOVALENT-CATION-STIMULATED ADENOSINE TRIPHOSPHATASE OF FROG SARTORIUS MICROSOMES. Biochim Biophys Acta (1965) 0.78
Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med (1974) 5.16
The histographic analysis of human muscle biopsies with regard to fiber types. 1. Adult male and female. Neurology (1969) 2.94
Selective and nonselective susceptibility of muscle fiber types. A new approach to human neuromuscular diseases. Arch Neurol (1970) 2.33
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects. Neurology (1977) 2.19
Benefit from alternate-day prednisone in myasthenia gravis. N Engl J Med (1972) 2.00
Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication. Proc Natl Acad Sci U S A (2001) 1.94
The histographic analysis of human muscle biopsies with regard to fiber types. 4. Children's biopsies. Neurology (1969) 1.93
Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med (1972) 1.90
Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone. Lancet (1983) 1.90
Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction. Lancet (1975) 1.84
Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies. J Neuropathol Exp Neurol (1996) 1.82
Ocular motor abnormalities in hereditary cerebellar ataxia. Brain (1976) 1.79
Single cholinergic receptor channel currents in cultured human muscle. J Neurosci (1982) 1.79
Oculocraniosomatic neuromuscular disease with "ragged-red" fibers. Arch Neurol (1972) 1.72
Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group. Neurology (1997) 1.70
Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med (1974) 1.69
The histographic analysis of human muscle biopsies with regard to fiber types. 2. Diseases of the upper and lower motor neuron. Neurology (1969) 1.64
Use of anti-neurofilament antibody to identify paired-helical filaments in inclusion-body myositis. Ann Neurol (1996) 1.51
beta-Amyloid precursor epitopes in muscle fibers of inclusion body myositis. Ann Neurol (1993) 1.49
Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol (1981) 1.48
Histochemical studies of denervated or tenotomized cat muscle: illustrating difficulties in relating experimental animal conditions to human neuromuscular diseases. Ann N Y Acad Sci (1966) 1.48
Myoglobinaemia in Duchenne muscular dystrophy patients and carriers: A new adjunct to carrier detection. Lancet (1978) 1.48
Type I fiber hypotrophy and central nuclei. A rare congenital muscle abnormality with a possible experimental model. Arch Neurol (1968) 1.47
Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am J Pathol (1992) 1.47
"Type grouping" in skeletal muscles after experimental reinnervation. Neurology (1968) 1.46
Tubular aggregates in type II muscle fibers: ultrastructural and histochemical correlation. J Ultrastruct Res (1970) 1.42
Acetazolamide treatment of hypokalemic periodic paralysis. Prevention of attacks and improvement of persistent weakness. Ann Intern Med (1970) 1.41
Paralysis of innervated cultured human muscle fibers affects enzymes differentially. J Neurochem (1990) 1.40
Effect of diphenylhydantoin on synaptosome sodium-potassium-ATPase. J Clin Invest (1968) 1.37
Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. Am J Pathol (1994) 1.37
Axonal transport of proteins in experimental neuropathies. Science (1969) 1.36
Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc Natl Acad Sci U S A (1996) 1.33
A new program for investigating adult human skeletal muscle grown aneurally in tissue culture. Neurology (1975) 1.31
Polymyositis: remarkable response to total body irradiation. Lancet (1981) 1.30
The histographic analysis of human muscle biopsies with regard to fiber types. 3. Myotonias, myasthenia gravis, and hypokalemic periodic paralysis. Neurology (1969) 1.29
The essentiality of histo- and cytochemical studies of skeletal muscle in the investigation of neuromuscular disease. 1962. Neurology (1998) 1.27
Experimental myopathy after microarterial embolization; comparison with childhood x-linked pseudohypertrophic muscular dystrophy. Arch Neurol (1970) 1.26
Duchenne muscular dystrophy: functional ischemia reproduces its characteristic lesions. Science (1971) 1.26
Histochemical investigation of fiber type ratios with the myofibrillar ATP-ase reaction in normal and denervated skeletal muscles of guinea pig. Am J Anat (1968) 1.22
Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease. J Neuropathol Exp Neurol (2001) 1.22
Impaired skeletal muscle maturation following neonatal neurectomy. Dev Biol (1968) 1.21
Neuronal trophic function. A new aspect demonstrated histochemically in developing soleus muscle. Arch Neurol (1967) 1.20
Correlative histochemical study of skeletal muscle after suprasegmental denervation, peripheral nerve section, and skeletal fixation. Neurology (1968) 1.20
Subacute sclerosing panencephalitis. Spontaneous improvement in a patient with elevated measles antibody in blood and spinal fluid. N Engl J Med (1968) 1.19
beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. Neuroreport (1993) 1.19
Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia. Neurology (2010) 1.19
Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies. Incidence and management. Arch Neurol (1984) 1.18
Increased plasma enzyme concentrations in rats with functional ischaemia of muscle provide a possible model of Duchenne muscular dystrophy. Nature (1972) 1.17
A histochemical-physiological correlation of frog skeletal muscle fibers. Am J Physiol (1967) 1.17
Acetazolamide prophylaxis in hypokalemic periodic paralysis. N Engl J Med (1968) 1.16
Neuromuscular disease in secondary hyperparathyroidism. Ann Intern Med (1975) 1.15
Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy. Neurosci Lett (1991) 1.15
Polyneuropathy with monoclonal gammopathy: studies of 11 patients. Ann Neurol (1981) 1.14
Rapid upregulation of caspase-3 in rat spinal cord after injury: mRNA, protein, and cellular localization correlates with apoptotic cell death. Exp Neurol (2000) 1.13
Refsum's disease--a recently characterized lipidosis involving the nervous system. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med (1967) 1.13
Open-biopsy electromyography. I. Correlation of motor unit behavior with histochemical muscle fiber type in human limb muscle. Arch Neurol (1972) 1.13
Ultrastructural localization of calcium in normal and abnormal skeletal muscle. Lab Invest (1977) 1.13
Slow saccades in spinocerebellar degeneration. Arch Neurol (1976) 1.13
Cardiac manifestations in polymyositis. Am J Cardiol (1978) 1.13
Intron-exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer's disease. J Biol Chem (2000) 1.13
High injection pressure during intralesional injection of corticosteroids into capillary hemangiomas. Arch Ophthalmol (2001) 1.11
The multiple ADP/ATP translocase genes are differentially expressed during human muscle development. J Biol Chem (1992) 1.11
Enhanced detection of congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique. Neurology (1993) 1.11
Scanning for soft-tissue amyloid. Lancet (1977) 1.10
Histochemical and contractile properties in the cross-innervated guinea pig soleus muscle. Arch Neurol (1969) 1.10
Thrombin: a potential proinflammatory mediator in neurotrauma and neurodegenerative disorders. Curr Drug Targets Inflamm Allergy (2004) 1.10
Muscle biopsies in neuromuscular diseases. Pediatr Clin North Am (1967) 1.10
Neuropathy in Tangier disease. Alpha-Lipoprotein deficiency manifesting as familial recurrent neuropathy and intestinal lipid storage. Arch Neurol (1967) 1.09
Gender-related differences in recovery of locomotor function after spinal cord injury in mice. Spinal Cord (2006) 1.09
Ultrastructural study of a peripheral nerve biopsy in Refsum's disease. J Neuropathol Exp Neurol (1969) 1.08
Atrophy of skeletal muscle in patients with Cushing's syndrome. Arch Neurol (1970) 1.08
The skeletal muscle binding site of antistriated muscle antibody in myasthenia gravis: an electron microscopic immunohistochemical study using peroxidase conjugated antibody fragments. J Immunol (1973) 1.07
Apoptosis in cellular compartments of rat spinal cord after severe contusion injury. J Neurotrauma (1998) 1.05
The pathogenesis of reactive axonal swellings: role of axonal transport. J Neuropathol Exp Neurol (1977) 1.05
A skeletal-muscle disorder associated with intermittent symptoms and a possible defect of lipid metabolism. N Engl J Med (1970) 1.04
Families with myotonic dystrophy with and without cardiac involvement. Arch Intern Med (1983) 1.04
Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis. Curr Opin Rheumatol (1998) 1.03
Does myasthenic serum bind to the neuromuscular junction? Ann N Y Acad Sci (1966) 1.03
Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging. Scand J Rheumatol (1998) 1.03
Modification by L-dopa of a case of progressive supranuclear palsy. With evidence of defective cerebral dopamine metabolism. Lancet (1970) 1.03
Phytanic acid in patients with Refsum's syndrome and response to dietary treatment. Arch Intern Med (1970) 1.03
Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation. J Neurosci (1998) 1.02
Apolipoprotein E immunoreactive deposits in inclusion-body muscle diseases. Lancet (1994) 1.02
Intravenous treatment of hypokalemic periodic paralysis. Arch Neurol (1983) 1.01
Focal myopathic changes produced by electromyographic and hypodermic needles. "Needle myopathy". Arch Neurol (1967) 1.01
The histologic diagnosis of neuromuscular diseases: a review of 79 biopsies. Arch Phys Med Rehabil (1966) 1.01
Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy. Am J Pathol (1998) 1.00
Transformation of the histochemical profile of skeletal muscle by "foreign" innervation. Nature (1967) 1.00
New advances in inclusion-body myositis. Curr Opin Rheumatol (1993) 1.00
Beta APP gene transfer into cultured human muscle induces inclusion-body myositis aspects. Neuroreport (1997) 1.00
Amyloidosis with plasma cell dyscrasia. An overlooked caused of adult onset sensorimotor neuropathy. Arch Neurol (1977) 0.99
Systemic manifestations of gyrate atrophy of the choroid and retina. Ophthalmology (1981) 0.99
Myasthenia gravis: a new hypothesis of the pathogenesis and a new form of treatment. Ann N Y Acad Sci (1971) 0.98
Brief, small, abundant motor-unit action potentials. A further critique of electromyographic interpretation. Neurology (1975) 0.98
Human schwann cells in tissue culture: histochemical and ultrastructural studies. Arch Neurol (1980) 0.98
Collagen localization in normal and fibrotic human skeletal muscle. Arch Neurol (1981) 0.98
Developmental regulation of amyloid precursor protein at the neuromuscular junction in mouse skeletal muscle. Mol Cell Neurosci (2000) 0.98
Strong immunoreactivity of alpha 1-antichymotrypsin co-localizes with beta-amyloid protein and ubiquitin in vacuolated muscle fibers of inclusion-body myositis. Acta Neuropathol (1993) 0.97
Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy. Arch Neurol (1980) 0.97
Novel immunolocalization of alpha-synuclein in human muscle of inclusion-body myositis, regenerating and necrotic muscle fibers, and at neuromuscular junctions. J Neuropathol Exp Neurol (2000) 0.97